OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
85
Results
Show all
Save search
Copy query
Show results for
Unknown
(85)
Publication Date
Release Date
2018
(31)
2020
(18)
2024
(6)
2021
(6)
2016
(6)
2025
(5)
2017
(4)
2022
(2)
2015
(2)
2014
(2)
2026
(1)
2023
(1)
2013
(1)
Previous
page
1 / 9
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
9
Next
page
Sort
by:
Relevance
Page size
10
Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive Protein.
Not available
S-EPMC4966337
|
biostudies-literature
Cite
Integrated Genomic Analysis Identifies UBTF Tandem Duplications as a Recurrent Lesion in Pediatric Acute Myeloid Leukemia.
Not available
S-EPMC9780084
|
biostudies-literature
Cite
Tumour evolution and microenvironment interactions in 2D and 3D space.
Not available
S-EPMC11525187
|
biostudies-literature
Cite
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.
Not available
S-EPMC5177991
|
biostudies-literature
Cite
Comprehensive molecular characterization of urothelial bladder carcinoma.
Not available
S-EPMC3962515
|
biostudies-literature
Cite
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.
Not available
S-EPMC4603750
|
biostudies-literature
Cite
Adjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast Cancer.
Not available
S-EPMC9126186
|
biostudies-literature
Cite
Genomic Classification of Cutaneous Melanoma.
Not available
S-EPMC4580370
|
biostudies-literature
Cite
Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels.
Not available
S-EPMC4740377
|
biostudies-literature
Cite
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.
Not available
S-EPMC5680778
|
biostudies-literature
Cite
Previous
page
1 / 9
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
9
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets